Peter Levine invented and developed the bio-psychological working paradigm known as Somatic Experiencing® to comprehend, prevent, and treat post-traumatic stress disorder and chronic stress.

An interventional study using Somatic Experiencing®, done on Breast cancer survivors, showed encouraging findings that support the use of this model to address the psychological effects of medical therapy and prolonged treatments for breast cancer. 

The study involved BC survivor women in Italy who had been diagnosed with 

The individuals, who were split into interventional and control groups, had :

At baseline, the survivors reported normal to borderline levels of depression and anxiety as well as a composite to impaired body image.

At the conclusion of the eight online group sessions, the women in the intervention group displayed improved psychological health. 

They had a considerable reduction in their levels of anxiety, depression, and distress symptoms. 

Results indicate that this model may help in developing more effective coping strategies and trauma reworking skills in terms of a decrease in anxious preoccupation and a greater forward focus. 

Additionally, it was seen that most of the women in the interventional group had a positive change in their perception of their bodies.

Punjab, Haryana, Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Maharashtra, NCT of Delhi, Odisha, Rajasthan, Uttar Pradesh, and West Bengal are among the worst affected states wherein the drug problem was widespread among children and adults alike. 

Nearly 7 lakh children (10-17 years) are abusers of substances like tobacco, alcohol, cocaine, heroin, opioids, sedatives, and inhalants. 

The most common substance abuse among school and college goers was tobacco, additionally-

The problem is also similarly widespread among adults, with over 66 lakh total abusers.  

21 lakh people are addicted to various kinds of opioids, including heroin.

According to WHO report on the global tobacco epidemic: "Protect People from Tobacco Smoke, 2023"-

The WHO's MPOWER policies have resulted in 300 million less smoking globally. 

The smoking prevalence fell from 22.8% to 17% from 2007-2021. 

Initiatives comprise of 

The report focuses on second-hand smoking that causes a major burden of many fatal diseases. 

It acknowledges India's achievements, with 85% of cigarette packs carrying warnings on both sides. 

India has also banned the sale of e-cigarettes and has comprehensive restrictions on tobacco advertising. 

Experts recommend additional measures such as 

The city of Bengaluru has been specially mentioned because of the 27% decrease in smoking 

This can be attributed to-

The city has gained worldwide acclaim for its tobacco control initiatives.

Lupin Pharmaceuticals Inc., Lupin's US subsidiary, has withdrawn two batches of Tydemy, an oral contraceptive, due to 'out of specification' outcomes at the 12-month stability check point. 

The recall is voluntary due to a considerable decrease in the amount of inactive content (ascorbic acid) in the product and went into effect following Lupin's notification to the US Food and Drug Administration on July 29. 

Tydemy lots that were impacted were distributed between June 3, 2022 and May 31, 2023.

The Vadodara Municipal Corporation's (VMC) Standing Committee has approved the restart of enriched flavoured milk delivery to Anganwadi children. 

During the Covid-19 epidemic in 2020, the distribution was halted. 

The ICDS department requested approval and a Rs 1.93 crore budget to offer fortified milk to 10,120 children at VMC Anganwadi six days a week.

Originally, milk was planned to be delivered twice a week, but it will now be delivered six days a week. 

The fortified milk contains Vitamin D and Vitamin A and will be given to each child attending the Anganwadi, with a possibility of 200 ml if there's a health requirement. 

The proposal also seeks approval for making advance payments to Baroda dairy and Amul, which supply the fortified flavoured milk to around 436 Anganwadi in the city. 

The United states center for disease control (CDC) approves a first ever vaccine against severe respiratory syncytial virus (RSV) disease. 

RSV is one of the most common causes of childhood respiratory sickness and the cause of death for 100 to 300 US children under the age of five per year. 

CDC found that use of the long-acting monoclonal antibody Nirsevimab, tradename BeyfortusTM, reduced the incidence of both hospitalizations and doctor visits for RSV in newborns by nearly 80%. 

CDC recommends single dose of Nirsevimab for all under 8 months, for their first RSV season and additional dose for immunocompromised children between the ages of 8 and 19 months.

According to an observational study published in The Lancet Infectious Diseases, a fourth dose of the bivalent (two-strain) COVID-19 vaccine is significantly more effective against medical treatment and hospitalization than a fourth monovalent (single-strain) dose among both previously infected and never-infected individuals who had received three monovalent doses. 

The study involved 2,749,829 participants and found that those who had never been exposed to COVID-19, a fourth dose of the monovalent vaccine did not provide any further protection over three doses against symptomatic infection while dose four of the bivalent vaccine did. 

The bivalent vaccine targets both the wild-type virus and the Omicron variant, as opposed to the monovalent which only targets the wild-type SARS-CoV-2.

US researchers developed an artificial intelligence model on chest X-rays. 

The AI analyses the distribution of fatty tissue and uses it to flag people with high risk of developing diabetes.

It ensures early diagnosis in individuals who may not be regularly screened for non-communicable diseases for example individuals with low BMI. 

The AI presents an exciting opportunity to extract data from routine tests to improve patient care. 

The researcher are next aiming to examine how well these X-rays can identify diseases such as chronic obstructive lung disease and congestive heart failure.

Twenty three  major and common cancers were analyzed as part of the cancer mortality trends study conducted from 2000 to 2019. 

The research, now published in a journal affiliated with the American Society of Clinical Oncology, was carried out at Amrita Hospital, Kochi, in collaboration with the World Health Organization. 

Pancreatic cancer showed the highest annual rise in mortality among both sexes at 2.7%. 

The study emphasizes the necessity for a comprehensive approach to tackle the escalating rates of cancer-related deaths in India, which include

To effectively respond to rising cases of dengue in the capital, healthcare facilities were directed by the government to set aside beds for dengue cases and maintain stock of requisite medications. 

1031 hotline, previously used for COVID, will now be used for Dengue. 

Physicians were advised to exercise caution when prescribing medications.

The educational sector was requested to ensure that students wore long-sleeved uniforms.  

The educational department has also been instructed to assign a dengue awareness assignment to students, in which they will draft a report on their own household’s dengue prevention preparedness.

Smoking kills 8.7 million people every year, making it one of the leading preventable causes of death. 

The UN health agency urged nations to increase their use of recognized tobacco-use prevention strategies, such as:

Globally, only 4 countries have successfully adopted all the WHO-recommended anti-tobacco measures. 

Currently, 71% of the world’s population is protected against smoking by at least one tobacco control measure, 5 times more than in 2007. 

However, 2.3 billion people still remain unprotected. 

Regarding the control measures on e-cigarettes, 121 countries have adopted some, and a total of 74 have no regulations in place for the same.

The Govt of India recently introduced a new category of visa known as the Ayush Visa. 

This visa will be available for foreign nationals who seek treatment under the Indian system of Medicine.       

It is a part of India’s roadmap for the “Heal in India” initiative. 

This will help in boosting the Medical Value Travel in India. 

According to the report “The Global Wellness Economy: Looking beyond COVID”, the global wellness economy is estimated to grow by 9.9% annually.

Also, Ayush based economy is estimated to grow by 70 billion by 2025. 

This initiative will help in making Indian traditional medicine a global phenomenon.